Trial NCT04340843

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2020-02187
Secondary IDs: 10330 NCI-2020-02187 UM1CA186686

Last trial update was posted on 2024-03-06

MeSH Interventions

Azacitidine Belinostat Decitabine Decitabine and cedazuridine drug combination Guadecitabine

MeSH Conditions

Chondrosarcoma

Other Conditions

Locally Advanced Unresectable Primary Central Chondrosarcoma Metastatic Primary Central Chondrosarcoma Unresectable Primary Central Chondrosarcoma

Stopping Reasons

Other - Completed stage 1 accrual

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID